- 14 March
-
At the end of the last year, Novouralsk-based Medsintez Plant turned 20 years old. Alexander Petrov, Chairman of the plant's Board of Directors, told Regions of Russia about the impressive successes that the company has achieved over the years and its ambitious plans for the future.
- 22 January
-
In 2023, the Medsintez Plant, in collaboration with the Promomed Group of Companies, launched the production of a full cycle of hypoglycemic drugs Enligria (liraglutide) and Quincenta (semaglutide) used in treating type II diabetes mellitus, including in patients with obesity and overweight or cardiovascular disease. The preparations are available in the most convenient and familiar for patients dosage form – a disposable prefilled injection and have already been supplied to pharmacies.
- 13 December
-
Medsintez Plant LLC presented the latest biotechnological developments of pharmaceuticals at the largest international scientific and practical forum in the field of medicine and health care Russian Health Care Week — 2023 held from December 4 to December 8 in Moscow. The main purpose of the Forum is to facilitate the implementation of the national projects “Healthcare” and “Demography”, “Tourism and Hospitality Industry”, the federal project “Development of Medical Services Export”, as well as summarizing the results of the Year of Science and Technology in Medicine.
- 04 October
-
On September 27, as part of the business program of the GMP conference with international participation, Alexander Petrov, Chairman of the Board of Directors of Medsintez Plant LLC, took part in a Plenary Session on the issues of regulating the circulation of medicines in Russia and the EAEU, developing import independence, and increasing export potential. The session was attended by representatives of the Ministry of Industry and Trade of the Russian Federation, the Minister of Health of the Republic of Nicaragua, the WHO Representative in Russia, a Representative of the Serbian Ministry of Health and other Russian and foreign experts. Mr. Petrov spoke about the problems that Russian pharmaceutical companies face when entering international markets and suggested possible solutions.
- Home
- Cluster members
- Vector-Medical Systems LLC
Vector-Medical Systems LLC
Since 1993, the medical and technical enterprise Vector-MS LLC has been specializing in the development and production of equipment for cardiology, cardiac surgery, functional diagnostics, physiotherapy, traumatology and rehabilitation.
Since 1993, the company has developed and put into mass production more than 10 medical devices.
The company includes a design office, pilot production, medical and technical department, marketing and sales department, as well as supporting services.
The company operates in five areas:
The first area is scientific research (R&D).
Based on the results of R&D, the company has obtained five patents.
The second area is the production of medical devices.
We produce:
1) External pacemakers:
- Transesophageal endocardial pacemaker CHEECS-3 «Vector-MS»
- For temporary external cardiac pacing in transesophageal, endocardial and transcutaneous modes.
- For the diagnostics and treatment of rhythm and conduction disorders of the heart.
- Programmable transesophageal and endocardial pacemaker CHEECSp-3 “Vector-MS”
Designed for electrophysiological studies of human cardiac activity, diagnostics and treatment of cardiac arrhythmias and conduction disorders in transesophageal and endocardial modes.
- Transesophageal endocardial and transcutaneous pacemaker CHEECS-5 “Vector-MS”
- diagnostics and treatment cardiac arrhythmias;
- conducting temporary pacemaking in order to stop arrhythmias in any conditions (including field ones) and maintain cardiac function in critical situations (ambulance) with simultaneous ECG monitoring in two leads;
- electrophysiological studies of the heart;
- intraoperative determination of the stimulation threshold and load impedance of the pacemaker of LLC «Vector-Medical Systems».
- Temporary wearable single-dual-chamber pacemaker ECS-VN-12 “Vector-MS”
For temporary endocardial stimulation of one or two cardiac chambers in patients with rhythm disturbances.
- Temporary portable transcutaneous transesophageal endocardial pacemaker ECS-VP-3 “Vector-MS”
For temporary transcutaneous, transesophageal and endocardial electrical stimulation of the heart when providing emergency care to patients with severe bradycardia, who are in serious condition due to extensive myocardial damage with severe disorders of central hemodynamics.
2) ELECTROSTIMULATOR ANALGETIC ESP-01- (according to A.A. Gerasimov) “Vector-MS”
Intratissual and transcutaneous electrical stimulation (ITES) according to the method of Doctor of Medical Sciences, Professor A.A. Gerasimov is a modern drug- free method for the treatment of diseases of the spine, joints, headaches and other pain syndromes.
3) Programmable transesophageal and endocardial pacemaker CHEECSp-3 “Vector-MS”
The production and maintenance of medical equipment is licensed (license of the Federal Service for Supervision in the Sphere of Health Care No. ФС-99-03-003878 dated 20/5/2013). All manufactured medical equipment has registration certificates of the Russian Federation.
The company sells its products both on the territory of the Russian Federation and in the CIS countries
The third area is maintenance of medical equipment.
In the scope of a maintenance license.
The fourth area is the supply of medical devices and consumables to healthcare institutions in Ekaterinburg and the Urals Federal District.
We are representatives of Inkart CJSC (St. Petersburg), Vilord LLC (Moscow), Neurosoft LLC (Ivanovo), Medicraft LLC and others.
The fifth area is the development of a home rehabilitation program.
Lease of medical equipment for rehabilitation.
Contacts:
50A, Bibliotechnaya St., Ekaterunburg, 620078
Tel.: +7 (343) 374-43-08, 216-26- 69
e-mail: market@vectorms.ru
www.vectorms.ru
